FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, biology, pharmacology. The method is characterised by the fact that biologically active sulphated polysaccharides (BASP) selected from the group: ungraded heparin, low-molecular heparin and fucoidan are mixed with a block copolymer of polyethylene oxide (PEO) and polyoxypropylene (POP). For effect enhancement, the block copolymer solution before mixed with BASP or the solution containing a BASP polymer is exposed to ionising irradiation.
EFFECT: method prevents desulphation of sulphated polysaccharides in a gastrointestinal tract and provides their oral bioavailability which considerably exceeds the oral bioavailability shown for sulphated polysaccharide (heparin) at an activity unit of introduced heparin.
19 cl, 6 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION ON THE BASIS OF FUCOIDAN FOR ORAL USE AND METHOD OF ITS PRODUCTION | 2017 |
|
RU2657615C1 |
ANTITHROMBOTIC AGENT OF SIBERIAN FIR CELLULOSE | 2014 |
|
RU2571555C1 |
METHOD FOR PREPARING HEPARIN WITH LOW MOLECULAR WEIGHT AND ANTICOAGULANT ACTIVITY | 2009 |
|
RU2396282C1 |
METHOD FOR MAKING LOW-MOLECULAR HEPARIN | 2007 |
|
RU2377993C2 |
HEPARIN OF AVERAGE MOLECULAR WEIGHT | 2000 |
|
RU2322245C2 |
IMMOBILISED BACILLUS LICHENIFORMIS BACTERIA PRODUCED SUBTILISIN SHOWING THROMBOLYTIC AND ANTICOAGULANT PROPERTIES | 2008 |
|
RU2416643C2 |
MICRONIZATION METHOD OF FUCOIDAN | 2019 |
|
RU2707872C1 |
METHOD FOR PREPARING LOW-MOLECULAR HEPARINS | 2003 |
|
RU2248801C2 |
NON-ANTICOAGULANT GLYCOSAMINOGLYCANS WITH REPEATING DISACCHARIDE UNITS, AND THEIR MEDICAL APPLICATION | 2012 |
|
RU2617764C2 |
ANTICOAGULANT | 2009 |
|
RU2399377C1 |
Authors
Dates
2011-06-20—Published
2009-07-23—Filed